Nancy E. Dempze’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,916
Closed -$233K 97
2024
Q4
$233K Sell
2,916
-4,227
-59% -$366K 0.13% 89
2024
Q3
$643K Sell
7,143
-10,091
-59% -$849K 0.36% 62
2024
Q2
$1.36M Sell
17,234
-70
-0.4% -$5.74K 0.93% 32
2024
Q1
$1.51M Buy
17,304
+1,770
+11% +$151K 1.15% 31
2023
Q4
$1.28M Buy
15,534
+265
+2% +$20.2K 1.07% 33
2023
Q3
$1.2M Buy
15,269
+1,385
+10% +$116K 1.07% 32
2023
Q2
$1.22M Buy
13,884
+2,491
+22% +$214K 1.05% 32
2023
Q1
$919K Buy
11,393
+3,117
+38% +$254K 0.84% 38
2022
Q4
$643K Sell
8,276
-1,633
-16% -$132K 0.63% 41
2022
Q3
$800K Buy
9,909
+2,866
+41% +$258K 0.85% 38
2022
Q2
$632K Buy
7,043
+3,566
+103% +$361K 0.63% 43
2022
Q1
$386K Buy
+3,477
New +$367K 0.28% 59

Other funds holding MDT

Nancy E. Dempze's MDT Position: Q1 2025 in Review

Nancy E. Dempze sold out of Medtronic (MDT) in Q1 2025, closing a stake of 2,916 shares — an estimated $233K sold.

Nancy E. Dempze first reported a position in MDT in Q1 2022 and held it in 12 quarters. The position peaked at $1.51M in Q1 2024. 2,177 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Nancy E. Dempze reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Nancy E. Dempze sold 2,916 Medtronic shares in Q1 2025, an estimated $233K.
  • Nancy E. Dempze first reported a position in Medtronic in Q1 2022 and held it in 12 quarters.
  • Nancy E. Dempze's Medtronic position peaked at $1.51M in Q1 2024.
  • 2,177 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Nancy E. Dempze's 13F filing for Q1 2025, filed 6 May 2025.